Youcare Pharmaceutical Group (688658.SH): YKYY025 injection is approved for FDA clinical trials.
Yuekang Pharmaceutical (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "...
Youcare Pharmaceutical Group (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "Hangzhou Tianlong") recently received a letter from the U.S. Food and Drug Administration (FDA) approving clinical trials of YKYY025 injection to prevent lower respiratory tract diseases caused by respiratory syncytial virus (RSV).
Related Articles
Guangzhou Sie Consulting (300687.SZ): The intelligent scheduling software technology research and development project based on model simulation led by the company has received official approval for project establishment.
ApicHope Pharmaceutical Group (300723.SZ): The Qinxin clearing oral liquid has been approved as a protected traditional Chinese medicine variety.
ApicHope Pharmaceutical Group (300723.SZ) joint venture company, American Arthrosi, may be acquired.
Guangzhou Sie Consulting (300687.SZ): The intelligent scheduling software technology research and development project based on model simulation led by the company has received official approval for project establishment.
ApicHope Pharmaceutical Group (300723.SZ): The Qinxin clearing oral liquid has been approved as a protected traditional Chinese medicine variety.
ApicHope Pharmaceutical Group (300723.SZ) joint venture company, American Arthrosi, may be acquired.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
